• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Hermes Impact Opportunities Equity Fund Class F GBP Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Hermes Investment Mgt
Fund Summary The investment objective of the Fund is to achieve long term capital appreciation by investing in companies which will benefit from meeting the worlds environmental and social challenges.
SEDOL code BD3FNV4
ISIN IE00BD3FNV41
Fund code HEIOA
Managers Tim Crockford
Manager Tenure 2 years
Morningstar Category Global Large-Cap Blend Equity
IMA Sector Global
Fund Size £211 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.95%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.2172
Buy Price £1.2172
Price Change +1.172%
Price Date 16th July 2019
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 21st December 2017
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018
Fund Performance +15.50%
Benchmark Performance
(Global Large-Cap Blend Equity)
+8.02%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day -0.58% -0.17% -0.41%
1 week -1.35% +2.44% -3.79%
1 month 1.82% +3.20% -1.38%
3 months 3.96% +5.66% -1.70%
6 months 13.79% +7.95% +5.84%
1 year 10.92% +3.26% +7.65%
3 years Currently unavailable +42.95% Currently unavailable
5 years Currently unavailable +60.47% Currently unavailable
10 years Currently unavailable +167.68% Currently unavailable
YTD 20.01% +13.64% +6.37%
Since inception 20.31% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Bank Rakyat Indonesia (Persero) Tbk Class B IDN 4.74%
Ecolab Inc USA 4.48%
Agilent Technologies Inc USA 4.37%
Novo Nordisk A/S B DNK 4.36%
Qiagen NV USA 4.25%
Hannon Armstrong Sustainable Infrastructure Capital Inc USA 4.18%
Ansys Inc USA 4.05%
Orsted A/S DNK 3.94%
Xylem Inc USA 3.93%
Sartorius AG Participating Preferred DEU 3.83%

Currently unavailable